Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Substance abuse treatment for people with schizophrenia.

Bellack AS, Gearon JS.

Addict Behav. 1998 Nov-Dec;23(6):749-66. Review.

PMID:
9801714
2.

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.

Arch Gen Psychiatry. 2006 Apr;63(4):426-32.

PMID:
16585472
3.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
4.

[Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].

Bechdolf A, Pohlmann B, Geyer C, Ferber C, Klosterkötter J, Gouzoulis-Mayfrank E.

Fortschr Neurol Psychiatr. 2005 Dec;73(12):728-35. Review. German.

PMID:
16355315
5.

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S.

Br J Psychiatry. 2003 Nov;183:418-26.

PMID:
14594917
6.

[Personality disorders and substance abuse disorders. Psychosocial strategies].

Lana Moliner F.

Actas Esp Psiquiatr. 2001 Jan-Feb;29(1):58-66. Review. Spanish.

PMID:
11333520
7.

Management of schizophrenia with substance use disorders.

Lybrand J, Caroff S.

Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Review.

PMID:
19944886
9.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
10.

Gender differences in patients with schizophrenia and substance abuse.

Brunette MF, Drake RE.

Compr Psychiatry. 1997 Mar-Apr;38(2):109-16.

PMID:
9056130
11.

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR.

Schizophr Bull. 1998;24(4):589-608. Review.

PMID:
9853791
12.

Psychosocial approaches to dual diagnosis.

Drake RE, Mueser KT.

Schizophr Bull. 2000;26(1):105-18. Review.

PMID:
10755672
13.

Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.

Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A.

Am J Drug Alcohol Abuse. 2008;34(1):75-82.

PMID:
18161645
14.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
16.
17.

CANTAB explicit memory is less impaired in addicted schizophrenia patients.

Potvin S, Briand C, Prouteau A, Bouchard RH, Lipp O, Lalonde P, Nicole L, Lesage A, Stip E.

Brain Cogn. 2005 Oct;59(1):38-42.

PMID:
15913868
18.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
20.

Mechanisms of action in integrated cognitive-behavioral treatment versus twelve-step facilitation for substance-dependent adults with comorbid major depression.

Glasner-Edwards S, Tate SR, McQuaid JR, Cummins K, Granholm E, Brown SA.

J Stud Alcohol Drugs. 2007 Sep;68(5):663-72.

PMID:
17690799

Supplemental Content

Support Center